# ENFLONSIA
> **BLA761432** · Biologics License Application · Sponsor: MERCK SHARP DOHME · Approved 2025-06-09
## Drug
- **FDA Application Number:** BLA761432
- **Application type:** Biologics License Application
- **Brand name:** ENFLONSIA
- **Generic name:** CLESROVIMAB
- **Active ingredients:** CLESROVIMAB-CFOR
- **Dosage form:** INJECTION
- **Route:** SOLUTION
- **Marketing status:** Prescription
- **Sponsor:** MERCK SHARP DOHME
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2025-06-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761432)
---
*MORVS · CC0 1.0*